Jul 29 |
Apple, Amazon, Microsoft, Meta Lead The Charge As Investors Bank On Tech Cheer For Rally's Reacceleration: Week Ahead In Earnings
|
Jul 29 |
Europe Just Turned Down Biogen's Alzheimer's Drug. Is the Stock One to Avoid, or a Bad News Buy?
|
Jul 29 |
Shares of Japan's Eisai tumble after EU rejects Alzheimer's drug
|
Jul 29 |
Eisai Shares Sink on Surprise EU Rejection of Alzheimer’s Drug
|
Jul 27 |
This Biogen Insider Increased Their Holding In The Last Year
|
Jul 26 |
EU Rejection of Alzheimer’s Drug Is Another Disappointment for Biogen
|
Jul 26 |
Biogen/Eisai's Alzheimer's Drug Leqembi Gets 'No Go' From European Drug Regulator's Advisory Panel, Cites Serious Side Events
|
Jul 26 |
The Zacks Analyst Blog Highlights Sage Therapeutics, Biogen Agenus and BioMarin Pharmaceutical
|
Jul 26 |
European committee says Alzheimer's treatment Leqembi shouldn't get marketing approval
|
Jul 26 |
Biogen Stock Tumbles After European Regulators Unexpectedly Reject Alzheimer's Drug
|